SearchingOACCU · NasdaqCIK 2029769Sponsor at IPO: Oaktree Acquisition Holdings III LS, LLC
Oaktree Acquisition Corp. III Life Sciences
$192MTrust raised at IPO
- IPO23 Oct 2024
- Searching24 months
- Deal announced—
- Closed—
Deadline before any extension: 25 Oct 2026 (24 months from the IPO closing). Extensions approved later are not added.
- 01
Larger than 51% of 2024’s SPAC IPOs.
$192M raised, against a median of $184M for the 55 SPACs that priced in 2024.
- 02
Original deadline October 2026.
24 months from the IPO closing, before any extension. No business combination agreement is in force.
Worked out from checked figures in snapshot 14 · no forecasts or advice
Key terms
Other 2024 SPAC IPOs →- IPO priced
- 23 Oct 2024
- IPO closed
- 25 Oct 2024
- Raised
- $192M
- Units sold
- 19,199,029
- Trust raised
- $192M1
- Trust per unit
- $10.002
- Unit
- 1 sh + ⅕ warrant3
- Months to complete
- 244
- Deadline before extensions
- 25 Oct 2026
- Over-allotment
- Exercised in part
Each unit: “one Class A ordinary share and one-fifth of one redeemable warrant”
How it compares
Oaktree Acquisition Corp. III Life Sciences against the 55 SPACs that priced in 2024.
- Raised
- $192M
- 51% of 2024 SPACs are below it
- 2024 median: $184M
- Trust per unit
- $10.00
- 51% of 2024 SPACs match it
- 2024 median: $10.00
- Months to complete
- 24
- 56% of 2024 SPACs match it
- 2024 median: 24
Trust and redemptions
No extension or merger vote with paid redemptions is on record for this SPAC yet.
Firms named in the prospectus
Company counsel
Underwriters’ counsel
Auditor
Sponsor
No other SPAC from Oaktree Acquisition Holdings III LS, LLC or a vehicle of the same name priced since 1 January 2019.
No SPAC named Oaktree Acquisition Life Sciences I and II is in our data. Each either priced before 1 January 2019, came to market under another name (SPACs are listed by their name at IPO), never came to market, or is not yet in an approved snapshot, so this record may understate the sponsor.
Peers
Other 2024 SPAC IPOs with Citigroup Global Markets Inc. as bookrunner.
| SPAC | IPO | Raised | Unit | Status |
|---|---|---|---|---|
| Churchill Capital Corp IX/Cayman | 1 May 2024 | $288M | 1 sh + ¼ warrant | Liquidated |
Sources
- PFinal prospectus: 0001193125-24-242948
- 1Trust raised: 0001193125-24-251274
As of October 30, 2024, a total of $191,990,290 of the net proceeds from the IPO (including the Option Units) and the sale of the Private Placement Units were placed in the Trust Account.
- 2Trust per unit: 0001193125-24-242948
$175,000,000, or $201,250,000 if the underwriters’ over-allotment option is exercised in full ($10.00 per unit in either case), will be deposited into a trust account located in the United States
- 3Unit composition: 0001193125-24-242948
Each unit has an offering price of $10.00 and consists of one Class A ordinary share, par value $0.0001 and one-fifth of one redeemable warrant.
- 4Months to complete: 0001193125-24-242948
If we do not consummate an initial business combination within 24 months from the closing of this offering or our board of directors approves an earlier liquidation, we will redeem 100% of the public shares for cash
Each quote is found word for word in the filing it cites. Where a figure here differs from the filing, the filing prevails.
How the figures are compiled
- Which IPOs. Every final IPO prospectus (Form 424B4 or 424B1, or a 424B3 when it is the first prospectus filed on an S-1 or F-1 registration within 10 days of it going effective) filed on SEC EDGAR from the history start, by a registrant whose SIC code was 6770 (blank checks) on the filing date. Offerings that are not exchange-listed SPAC IPOs are excluded when the prospectus is read. The window starts on 1 January 2021.
- Dated by. The date of the final prospectus.
- Raised. Units sold to the public, including over-allotment units, times the unit price, as stated in the SPAC's 8-K reports after the IPO.
- Trust. The trust held for public shareholders after the IPO and any over-allotment: trust per unit times public units, as stated in the SPAC's filings. Cash deposited in trust and then moved out as working capital is not counted.
- Bookrunners. Firms the prospectus names as book-running managers; where it names none, the firm it names as sole underwriter or representative of the underwriters. Only the prospectus's own wording counts, not later 8-K reports. Each IPO's gross proceeds are split equally among its bookrunners.
- Counsel and auditors. Issuer counsel and underwriters' counsel as named in the prospectus's Legal Matters section; the auditor as named in its Experts section. Each is credited with the IPO's full gross proceeds.
- Unit structure. What one unit consists of, as the prospectus states it: a share with warrants, with rights, with both, or a share alone (shares-only offerings sell no units). Warrants per unit is the fraction of a warrant in each unit; rights are measured as the fraction of a share they convert into per unit.
- Trust per unit. Dollars placed in the trust account for each unit sold to the public, as the prospectus states it.
- Time to complete. Months from the IPO closing that the SPAC has to complete its business combination before any extension, as the prospectus states it.
- Over-allotment. Whether the underwriters bought all, part or none of the over-allotment option, comparing units sold with the base offering and the option.
- Votes. Shareholder votes to extend a SPAC's deadline or to approve its business combination, as reported in its 8-Ks (Item 5.07), for the SPACs in the IPO statistics only: SPACs that priced before the history start are not included, so votes in the first years under-represent the market. Only redemptions actually paid count: votes on a proposal that failed, or an extension that was approved but never took effect, are left out (redemption requests lapse with them), and a merger vote counts only when the deal closed, and only the last merger vote before the closing, since merger redemptions are paid at closing. Liquidation votes are left out too, as every public share is redeemed by definition.
- Redemption rate. Public shares redeemed at a vote over public shares outstanding just before it. Shares redeemed are as an 8-K, or failing that the next 10-Q or 10-K, states them. Shares before are as a filing states them, or redeemed plus the shares left after, or carried from the IPO's public shares and earlier votes. The median is the typical vote; the weighted rate divides all shares redeemed by all shares before, the share of public money that left the trusts. A vote counts only when each of these figures is verified or accepted. Votes whose redemption count no filing states, after a search of the SPAC's and the combined company's filings, are counted as not disclosed rather than estimated.
- Outcomes. Where each SPAC stands as of the snapshot: completed (business combination closed), liquidated (trust returned and redeemed), deal pending (agreement signed, not closed) or searching (no agreement in force). Grouped by the year the SPAC priced its IPO. Awaiting review means its status is still being checked.
- Closings. Completed business combinations by year of closing. The sector is the SEC's industry code (SIC) of the combined company, grouped into broad sectors; months from IPO run from the prospectus date to the closing.
- Checking. A SPAC counts only when every required figure is verified (quote found verbatim in the filing and all cross-checks pass) or accepted by a named reviewer.
- Coverage. 1,077 of the 1,089 SPAC IPOs read are counted; 12 wait on a figure still under review and 11 filings were excluded as not exchange-listed SPAC IPOs.
Compiled from SEC filings with the assistance of AI · figures as of 3 November 2026
For information only. These figures are compiled from SEC filings with the assistance of AI. Although they are checked against those filings, they may contain errors or omissions and have not been audited; where they differ from the filings, the filings prevail. They are not an offer to sell, a solicitation of an offer to buy, or a recommendation of any security. Information about any SPAC is qualified in its entirety by its filings with the SEC, available at www.sec.gov.